Vivos (RDGL) Payables (2010 - 2025)

Vivos' (RDGL) quarterly Payables came in at $92472.0 in Q4 2025, up 7.26% year-on-year from $86209.0 in Q4 2024, and down 17.94% quarter-over-quarter from $112693.0 in Q3 2025.

Vivos (RDGL) Payables (2010 - 2025) Analysis & Trends

Vivos has disclosed Payables across 16 years of filings, most recently posting $92472.0 for Q4 2025.

  • Payables for Q4 2025 came in at $92472.0, up 7.26% year-over-year; the trailing twelve-month figure through Dec 2025 was $92472.0 (up 7.26% YoY), and the FY2025 annual result was $92472.0, up 7.26% from the prior year.
  • Payables came in at $92472.0 for Q4 2025 at Vivos, down from $112693.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $443345.0 in Q1 2021 to a low of $48820.0 in Q3 2024.
  • The 5-year median for Payables is $112751.5 (2023), against an average of $149963.0.
  • Across the five-year window, Payables soared 2855.63% in 2021 and tumbled 80.71% in 2022, its largest moves.
  • Vivos' Payables stood at $166915.0 in 2021, then tumbled by 51.06% to $81692.0 in 2022, then soared by 199.91% to $245004.0 in 2023, then slumped by 64.81% to $86209.0 in 2024, then increased by 7.26% to $92472.0 in 2025.
  • The last three Payables figures came in at $92472.0 (Q4 2025), $112693.0 (Q3 2025), and $96458.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 5.78 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 1.93 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 2.57 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 181.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.33 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 2.07 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 3.42 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 457.70 Mn
10 Vivos - - -3,105.00 92,472.00

Historic Data

Download Data
DateValue
Dec 31, 2025 92,472.00
Sep 30, 2025 112,693.00
Jun 30, 2025 96,458.00
Mar 31, 2025 115,378.00
Dec 31, 2024 86,209.00
Sep 30, 2024 48,820.00
Jun 30, 2024 166,560.00
Mar 31, 2024 74,766.00
Dec 31, 2023 245,004.00
Sep 30, 2023 107,369.00
Jun 30, 2023 112,810.00
Mar 31, 2023 48,989.00
Dec 31, 2022 81,692.00
Sep 30, 2022 160,953.00
Jun 30, 2022 215,093.00
Mar 31, 2022 85,515.00
Dec 31, 2021 166,915.00
Sep 30, 2021 269,110.00
Jun 30, 2021 269,110.00
Mar 31, 2021 443,345.00